These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


205 related items for PubMed ID: 29717459

  • 21. [Digital droplet PCR - a prospective technological approach to quantitative profiling of microRNA].
    Kiseleva YY, Ptitsyn KG, Radko SP, Zgoda VG, Archakov AI.
    Biomed Khim; 2016 May; 62(4):403-10. PubMed ID: 27562993
    [Abstract] [Full Text] [Related]

  • 22. Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis.
    Precazzini F, Detassis S, Imperatori AS, Denti MA, Campomenosi P.
    Int J Mol Sci; 2021 Jan 25; 22(3):. PubMed ID: 33503982
    [Abstract] [Full Text] [Related]

  • 23. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S, Tran N.
    Biomark Med; 2015 Jan 25; 9(2):131-51. PubMed ID: 25689901
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of reverse-transcriptase qPCR and droplet digital PCR for the quantification of dengue virus nucleic acid.
    Abachin E, Convers S, Falque S, Esson R, Mallet L, Nougarede N.
    Biologicals; 2018 Mar 25; 52():49-54. PubMed ID: 29398345
    [Abstract] [Full Text] [Related]

  • 26. Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.
    Kloten V, Neumann MHD, Di Pasquale F, Sprenger-Haussels M, Shaffer JM, Schlumpberger M, Herdean A, Betsou F, Ammerlaan W, Af Hällström T, Serkkola E, Forsman T, Lianidou E, Sjöback R, Kubista M, Bender S, Lampignano R, Krahn T, Schlange T, CANCER-ID consortium.
    Clin Chem; 2019 Sep 25; 65(9):1132-1140. PubMed ID: 31235535
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Assessment of Urinary MicroRNAs by Quantitative Polymerase Chain Reaction in Diabetic Nephropathy Patients.
    Newbury LJ, Wonnacott A, Simpson K, Bowen T, Fraser D.
    Methods Mol Biol; 2020 Sep 25; 2067():277-285. PubMed ID: 31701457
    [Abstract] [Full Text] [Related]

  • 29. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage.
    Wang H, Peng R, Wang J, Qin Z, Xue L.
    Clin Epigenetics; 2018 Sep 25; 10():59. PubMed ID: 29713393
    [Abstract] [Full Text] [Related]

  • 30. Digital PCR analysis of circulating nucleic acids.
    Hudecova I.
    Clin Biochem; 2015 Oct 25; 48(15):948-56. PubMed ID: 25828047
    [Abstract] [Full Text] [Related]

  • 31. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
    Masuda T, Shinden Y, Noda M, Ueo H, Hu Q, Yoshikawa Y, Tsuruda Y, Kuroda Y, Ito S, Eguchi H, Ohno S, Mimori K.
    Anticancer Res; 2018 Aug 25; 38(8):4515-4523. PubMed ID: 30061217
    [Abstract] [Full Text] [Related]

  • 32. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.
    Rapado-González Ó, López-López R, López-Cedrún JL, Triana-Martínez G, Muinelo-Romay L, Suárez-Cunqueiro MM.
    Cells; 2019 Dec 17; 8(12):. PubMed ID: 31861130
    [Abstract] [Full Text] [Related]

  • 33. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
    Brunet-Vega A, Pericay C, Quílez ME, Ramírez-Lázaro MJ, Calvet X, Lario S.
    Anal Biochem; 2015 Nov 01; 488():28-35. PubMed ID: 26271186
    [Abstract] [Full Text] [Related]

  • 34. Liquid Profiling in Lung Cancer - Quantification of Extracellular miRNAs in Bronchial Lavage.
    Schmidt B, Rehbein G, Fleischhacker M.
    Adv Exp Med Biol; 2016 Nov 01; 924():33-37. PubMed ID: 27753015
    [Abstract] [Full Text] [Related]

  • 35. Isolation and Quantification of MicroRNAs from Human Saliva.
    Arunachalam SR, Tang KD, Punyadeera C.
    Methods Mol Biol; 2019 Nov 01; 2054():105-114. PubMed ID: 31482450
    [Abstract] [Full Text] [Related]

  • 36. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C.
    Int J Cancer; 2013 Jan 01; 132(1):116-27. PubMed ID: 22674182
    [Abstract] [Full Text] [Related]

  • 37. Identification and Use of Personalized Genomic Markers for Monitoring Circulating Tumor DNA.
    Chen Y, George AM, Olsson E, Saal LH.
    Methods Mol Biol; 2018 Jan 01; 1768():303-322. PubMed ID: 29717450
    [Abstract] [Full Text] [Related]

  • 38. Detection of Cancer DNA in Early Stage and Metastatic Breast Cancer Patients.
    Medford AJ, Gillani RN, Park BH.
    Methods Mol Biol; 2018 Jan 01; 1768():209-227. PubMed ID: 29717446
    [Abstract] [Full Text] [Related]

  • 39. The Introduction and Clinical Application of Cell-Free Tumor DNA.
    Li J, Liu R, Huang C, Chen S, Xu M.
    Methods Mol Biol; 2018 Jan 01; 1754():45-65. PubMed ID: 29536437
    [Abstract] [Full Text] [Related]

  • 40. IDH1 mutation detection by droplet digital PCR in glioma.
    Wang J, Zhao YY, Li JF, Guo CC, Chen FR, Su HK, Zhao HF, Long YK, Shao JY, To Ss, Chen ZP.
    Oncotarget; 2015 Nov 24; 6(37):39651-60. PubMed ID: 26485760
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.